Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tectonic Therapeutic, Inc.

TECX Clue Score49
United States Fiscal year ends December CIK 0001681087 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Terrance McGuire
7 Apr 2025
Director
Sell indirect
500,000
$17.10
$8.55M
Geoffrey Mackay
12 Feb 2020
See Remarks
Sell
1,400
$29.07
$40.69K
Geoffrey Mackay
11 Feb 2020
See Remarks
Sell
18,404
$28.10
$517.10K
Geoffrey Mackay
11 Feb 2020
See Remarks
Sell
44,596
$27.36
$1.22M
Christopher Paige
11 Feb 2020
Director
Sell
15,000
$28.00
$420.00K
Christopher Paige
28 Jan 2020
Director
Sell
10,000
$23.00
$230.00K
Geoffrey Mackay
8 Apr 2019
See Remarks
Sell
698
$27.07
$18.89K
Christopher Paige
8 Apr 2019
Director
Sell
100
$26.92
$2.69K
Christopher Paige
8 Apr 2019
Director
Sell
2,400
$25.84
$62.02K
Geoffrey Mackay
5 Apr 2019
See Remarks
Sell
13,302
$27.26
$362.62K
Christopher Paige
5 Apr 2019
Director
Sell
867
$26.21
$22.72K
Christopher Paige
5 Apr 2019
Director
Sell
6,633
$25.59
$169.76K

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 5
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 32,689,931
Sales filed before the plan box existed 11
History held since 22 Jun 2018